Abstract
Treatment strategies and treatment options have changed considerably over the past decade for Inflammatory Bowel Disease (IBD). Alongside this shift in therapeutic options has come an opportunity to personalize treatment decisions based on individual patient profiles and preferences. One of the most important aspects of therapy in IBD is treatment related risk, and an opportunity exists to personalize therapy through optimization of drug safety profiles in individual patients. In this review we discuss the potential risks of therapy in IBD, opportunities to mitigate those risks, and a personalized approach to consider when using these agents in clinical practice.
Keywords: Crohn's disease, ulcerative colitis, risk, adverse events, inflammatory bowel disease, infections
Current Drug Targets
Title:Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach
Volume: 19 Issue: 7
Author(s): Parambir S. Dulai and Corey A. Siegel*
Affiliation:
- Dartmouth-Hitchcock Medical Center, Lebanon, NH,United States
Keywords: Crohn's disease, ulcerative colitis, risk, adverse events, inflammatory bowel disease, infections
Abstract: Treatment strategies and treatment options have changed considerably over the past decade for Inflammatory Bowel Disease (IBD). Alongside this shift in therapeutic options has come an opportunity to personalize treatment decisions based on individual patient profiles and preferences. One of the most important aspects of therapy in IBD is treatment related risk, and an opportunity exists to personalize therapy through optimization of drug safety profiles in individual patients. In this review we discuss the potential risks of therapy in IBD, opportunities to mitigate those risks, and a personalized approach to consider when using these agents in clinical practice.
Export Options
About this article
Cite this article as:
Dulai S. Parambir and Siegel A. Corey *, Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach, Current Drug Targets 2018; 19 (7) . https://dx.doi.org/10.2174/1389450118666170525114939
DOI https://dx.doi.org/10.2174/1389450118666170525114939 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toll-Like Receptors in Skin Infections and Inflammatory Diseases
Infectious Disorders - Drug Targets The Need for Diagnostic Criteria in Systemic Vasculitis
Current Immunology Reviews (Discontinued) Drug Interactions During Periodontal Therapy in HIV-Infected Subjects
Mini-Reviews in Medicinal Chemistry Macrophage Heterogeneity: Relevance and Functional Implications in Atherosclerosis
Current Vascular Pharmacology Current Research on Opioid Receptor Function
Current Drug Targets The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals New Developments in Therapeutic Agents for Legionnaires Disease
Anti-Infective Agents in Medicinal Chemistry Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
Current Protein & Peptide Science Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Vaccine Therapy for P. acnes-Associated Diseases
Infectious Disorders - Drug Targets Production of Fibrinolytic Protease from a Halobacterium <i>Bacillus licheniformis</i> VITLMS Isolated from Marine Sponges of Rameshwaram Coast, India
Current Bioactive Compounds Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
Current Pharmaceutical Design Multiple Drugs Causing Severe Anemia in Infective Endocarditis
Cardiovascular & Hematological Disorders-Drug Targets Postoperative Complications in Hemorrhoidal Disease and Special Conditions
Reviews on Recent Clinical Trials Concurrent Methicillin-Resistant <i>Staphylococcus aureus Septicemia</i> and Thyroid Abscess in a Young Male with Dengue
Infectious Disorders - Drug Targets Reducing the Development of Antibiotic Resistance in Critical Care Units
Current Pharmaceutical Biotechnology The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Drugs in Pediatric Ischemic Stroke
Current Drug Targets Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology